Celularity (CELU) Competitor Comparison
We are evaluating the key criteria listed to compare Celularity (CELU) against its competitors in the Biotechnology industry.
Market Capitalization
267 / 368Gross Profits
155 / 278Total Revenue
170 / 300EBITDA
190 / 337Free Cashflow
117 / 352Quick Ratio
355 / 357Earnings per Share
357 / 359Dividend yield
0 / 6Total Cash
354 / 358Performance 3 years
331 / 368Performance 5 years
345 / 368Performance 10 years
312 / 368Linearity 3 years
240 / 368Linearity 5 years
228 / 368Linearity 10 years
176 / 367Total Rank
80 / 368Dividend Rank
82 / 368Valuation Rank
313 / 368Piotroski Rank
265 / 368Muliplier Rank
52 / 368Market Capitalization - CELU ranking 267 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.